Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Individual Patient Expanded Access for Human Acellular Vessel (HAV)

Next Previous
X
Search
Trial Profile

Individual Patient Expanded Access for Human Acellular Vessel (HAV)

Status: Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 22 Aug 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Human acellular vessel-Humacyte (Primary)
  • Indications Cardiovascular disorders; Congenital heart defects; Ischaemia; Renal failure; Type 1 diabetes mellitus; Vascular injuries
  • Focus Expanded access; Therapeutic Use
  • Sponsors Humacyte

    • Most Recent Events

    • 29 Jun 2022 According to a Humacyte media release, data from the first series of compassionate use cases of the HAV for the treatment of critical limb ischemia from this study were also recently published online in the Annals of Vascular Surgery.
    • 31 Jan 2022 Results published in the Media Release
    • 12 Nov 2021 According to a Humacyte media release, company has completed the 15th implant in the U.S. under this program.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top